12/09/2025
Are GLP-1 drugs (Ozempic/Zepbound) affecting cancer risk? VCU Massey is providing the critical perspective needed for this national conversation.
We are proud to see Dr. Kandace McGuire, Chief of Breast Surgery, quoted in NBC News providing expert analysis on the recent study of GLP-1 drugs and their link to obesity-related cancers.
Dr. McGuire advises caution regarding the study's short-term findings, stressing the need for long-term data.
Read the full article to understand the study's limitations and why experts say more data is needed:
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes and obesity.